Ono Pharmaceutical Co., Ltd.
OPHLY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $139 | $205 | $161 |
| Short-Term Investments | $0 | $0 | $6 | $10 |
| Receivables | $1 | $144 | $135 | $152 |
| Inventory | $0 | $71 | $75 | $78 |
| Other Curr. Assets | $0 | $33 | $35 | $31 |
| Total Curr. Assets | $3 | $387 | $455 | $432 |
| Property Plant & Equip (Net) | $1 | $104 | $106 | $107 |
| Goodwill | $0 | $21 | $21 | $22 |
| Intangibles | $2 | $360 | $330 | $355 |
| Long-Term Investments | $1 | $90 | $89 | $111 |
| Tax Assets | $0 | $0 | $51 | $0 |
| Other NC Assets | $0 | $63 | $12 | $56 |
| Total NC Assets | $4 | $637 | $609 | $650 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $7 | $1,024 | $1,064 | $1,082 |
| Liabilities | – | – | – | – |
| Payables | $0 | $63 | $89 | $61 |
| Short-Term Debt | $0 | $30 | $30 | $30 |
| Tax Payable | $0 | $0 | $4 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $33 | $22 | $28 |
| Total Curr. Liab. | $1 | $129 | $148 | $122 |
| LT Debt | $1 | $98 | $105 | $113 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $11 | $0 |
| Other NC Liab. | $0 | $11 | $3 | $18 |
| Total NC Liab. | $1 | $116 | $128 | $139 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $11 | $12 | $12 |
| Total Liabilities | $2 | $245 | $276 | $261 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $17 | $17 | $17 |
| Retained Earnings | $6 | $790 | $791 | $792 |
| AOCI | $0 | $28 | $20 | $70 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $5 | $773 | $782 | $816 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $6 | $6 | $6 |
| Total Liab. & Tot. Equity | $7 | $1,024 | $1,064 | $1,082 |
| Net Debt | -$0 | -$11 | -$70 | -$18 |